139 related articles for article (PubMed ID: 23378685)
1. Comparison of architect I 2000 for determination of cyclosporine with axsym.
Serdarevic N; Zunic L
Acta Inform Med; 2012 Dec; 20(4):214-7. PubMed ID: 23378685
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Architect i2000 for determination of Scc with IMX determination of SCC with different methods.
Serdarevic N; Stanciu AE
Clin Lab; 2013; 59(9-10):1129-33. PubMed ID: 24273937
[TBL] [Abstract][Full Text] [Related]
3. Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay.
Wallemacq P; Maine GT; Berg K; Rosiere T; Marquet P; Aimo G; Mengozzi G; Young J; Wonigeit K; Kretschmer R; Wermuth B; Schmid RW
Ther Drug Monit; 2010 Apr; 32(2):145-51. PubMed ID: 20216110
[TBL] [Abstract][Full Text] [Related]
4. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)].
Petitjean Lecherbonnier J; Gouarin S; Dina J; Vabret A; Freymuth F
Pathol Biol (Paris); 2007 Dec; 55(10):512-20. PubMed ID: 17959324
[TBL] [Abstract][Full Text] [Related]
6. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
Hermida-Cadahia EF; Tutor JC
Scand J Clin Lab Invest; 2012 Apr; 72(2):180-3. PubMed ID: 22248047
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassay.
Sabaté I; Ginard M; González JM; Baró E; Acebes G; Cuadros J; Lirón FJ
Ther Drug Monit; 2000 Aug; 22(4):474-80. PubMed ID: 10942190
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.
Hamwi A; Veitl M; Männer G; Ruzicka K; Schweiger C; Szekeres T
Am J Clin Pathol; 1999 Sep; 112(3):358-65. PubMed ID: 10478141
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
12. Comparing the digoxin test with the Architect® i1000sr system with respect to the AxSYM® system.
Albert Vicent E; Ferriols Lisart R; Roch Ventura MA; Alós Almiñana M
Farm Hosp; 2011; 35(5):256-9. PubMed ID: 21514866
[TBL] [Abstract][Full Text] [Related]
13. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
14. Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.
Regazzi MB; Molinaro M; Tinelli C; D'Eril GM; Goggi C; Campana C; Fiorito V; Moratti R; Viganò M
Ther Drug Monit; 2000 Dec; 22(6):712-5. PubMed ID: 11128239
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.
Bergan S; Rugstad HE; Stokke O; Bentdal O; Frøysaker T; Bergan A
Scand J Clin Lab Invest; 1993 Aug; 53(5):471-7. PubMed ID: 8210969
[TBL] [Abstract][Full Text] [Related]
16. Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity.
Brate EM; Finley DM; Grote J; Holets-McCormack S; Ozaeta PF; Pacenti D; Peart JE; Piktel RE; Ramsay CS; Rupprecht KR; Saldana SC; Spring TG; Tetin SY; Trudeau BC; Wang P; Xie H
Clin Biochem; 2010 Sep; 43(13-14):1152-7. PubMed ID: 20599875
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
[TBL] [Abstract][Full Text] [Related]
18. Degradation of vancomycin in external quality assessment samples is a factor to underestimate its concentration.
Fan Y; Wang Y; Chen M; Chen Y; Guo B; Liu X; Wu H; Li Y; Hu J; Zhang J
Bioanalysis; 2021 Nov; ():. PubMed ID: 34789003
[No Abstract] [Full Text] [Related]
19. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
[TBL] [Abstract][Full Text] [Related]
20. Performance characteristics of the ARCHITECT Active-B12 (Holotranscobalamin) assay.
Merrigan SD; Owen WE; Straseski JA
Clin Lab; 2015; 61(3-4):283-8. PubMed ID: 25974994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
